GenRx Entecavir entecavir (as monohydrate) 1mg tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

entecavir, Quantity: 1 mg

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

Entecavir

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: lactose monohydrate; hyprolose; crospovidone; magnesium stearate; titanium dioxide; iron oxide red; microcrystalline cellulose; macrogol 8000; copovidone; hypromellose

Vía de administración:

Oral

Unidades en paquete:

30

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Resumen del producto:

Visual Identification: Pink colored, triangular shaped film coated tablets, engraved 'APO' on one side and '1' over 'ENT' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2016-03-10